Atomo Diagnostics Company

Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Manufacturing, Medical Device
Headquarters: Leichhardt, New South Wales, Australia
Founded Date: 2010-01-01
Employees Number: 11-50
Funding Status: IPO
Estimated Revenue: $10M to $50M
Last Funding Date: 2017-02-01
Last Funding Type: Convertible Note

Visit Website
info@atomodiagnostics.com
https://twitter.com/atomodiagnostic
Register and Claim Ownership